EG Acquisition Corp.
EGGF-UN News Today: Stay Updated with the Latest EG Acquisition Corp. News in Real Time
Find EGGF-UN news now at Meyka AI. Stay informed with the latest EG Acquisition Corp. stocks updates, including price news, market analysis, and expert insights.
Canadian Citizenship for Americans March 31: Bill C-3 Drives Surge
Canadian citizenship forAmer interest is surging after Bill C-3 ended the first‑generation limit on citizenship by descent, driving a 10x spike in Nova Scotia archives requests.
BX Stock Today, March 31: Sells $1.4B Madrid Homes to Brookfield
Blackstone Madrid sale: BX sells 5,000 Madrid apartments to Brookfield for $1.4B. What it means for BX and BAM stocks, US investors, and near‑term catalysts.
EOM.CN Eco Oro Minerals (CNQ) up 80% on heavy volume 401000 01 Apr 2026: Monitor catalysts
EOM.CN stock jumps 80% to C$0.045 on heavy volume; fundamentals weak but short-term catalysts support a cautious outlook
Australia Card Surcharge Ban April 01: RBA Caps Fees, Boosts Transparency
From 1 Oct 2026, the credit card surcharge ends as the RBA caps interchange and forces fee transparency across eftpos, Mastercard and Visa. See winners, risks.
Evercore ISI Maintains Negative on MA (Mastercard Incorporated) March 2026
Evercore ISI maintains Negative on MA; read implications of the MA analyst rating and Meyka AI market analysis
AMMP.CN AmmPower Corp. CNQ 31 Mar 2026: Shares at C$0.03 signal oversold bounce
AMMP.CN stock trades at C$0.03 on CNQ. Oversold bounce setup with heavy volume and model forecast C$0.06 upside.
Pre-market Most Active: 9434.T SoftBank JPX JPY 211.10 01 Apr 2026: high volume
Pre-market update on 9434.T stock at JPY 211.10 with high volume and analyst context from Meyka AI
Biogen to Buy Apellis in $5.6 Billion All‑Cash Deal
Biotech giant Biogen announced a major deal to acquire Apellis Pharmaceuticals for $5.6 billion in cash, marking one of the largest strategic transactions in the sector this year. The acquisition is aimed at strengthening Biogen’s drug pipeline, especially in areas such as eye disease and immunology where Apellis has developed promising therapies. Investors reacted strongly…
Centessa Shares Soar Following Lilly’s $6.3B Acquisition Announcement
The stock market reacted strongly after a major acquisition announcement involving Centessa Shares. Eli Lilly, one of the largest pharmaceutical companies in the world, confirmed it will acquire Centessa Pharmaceuticals for $6.3 billion in an all‑cash deal. This news caused Centessa Shares to surge sharply, making the acquisition one of the most talked‑about deals in…